首页 正文

Optimization and production of a GLP-grade recombinant Sm29 vaccine against schistosomiasis: From expression to preclinical assessment

{{output}}
Schistosomiasis remains a major neglected tropical disease, and the development of a safe, effective vaccine is a global priority. Sm29, a Schistosoma mansoni surface antigen associated with naturally acquired resistance, has emerged as a promising vaccine can... ...